Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials.
Linda G MellbinDeepak L BhattJens-Peter DavidKathrine EkströmMark C PetrieSøren RasmussenTina VilsbøllPublished in: European heart journal (2024)